Efficacy of mouth rinse in preventing oral mucositis in patients receiving high-dose cytarabine for allogeneic hematopoietic stem cell transplantation

International Journal of Hematology

Volumn 88, Issue 5, 2009, Pages 583-587

  Mori, Takehiko ^a   Hasegawa, Kaori ^b   Okabe, Ai ^b   Tsujimura, Natsuki ^b   Kawata, Yusuke ^b   Yashima, Tomoko ^b   Kobayashi, Naoko ^b   Kondo, Sakiko ^b   Aisa, Yoshinobu ^a   Kato, Jun ^a   Tsunoda, Kazuyuki ^a   Nagai, Tetsuo ^a   Nakagawa, Taneaki ^a   Shigematsu, Naoyuki ^a   Kubo, Atsushi ^a   Ikeda, Yasuo ^a   Okamoto, Shinichiro ^a  

^a KEIO UNIVERSITY   (Japan)

^b KEIO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Hematopoietic stem cell transplantation; High dose cytarabine; Mouth rinse; Oral mucositis

Indexed keywords

CYCLOSPORIN A; CYTARABINE; METHOTREXATE; MOUTHWASH; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EXCRETION; DRUG INFUSION; DRUG MEGADOSE; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOUTH HYGIENE; MOUTH INFLAMMATION; MUCOSA INFLAMMATION; MYELODYSPLASTIC SYNDROME; SALIVA; THERAPY EFFECT; TREATMENT DURATION; WHOLE BODY RADIATION; ALLOTRANSPLANTATION; BLOOD DISEASE; CHEMICALLY INDUCED DISORDER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INCIDENCE; MIDDLE AGED; STOMATITIS;

ADULT; CYTARABINE; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; ORAL HYGIENE; STOMATITIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; WHOLE-BODY IRRADIATION;

EID: 64249095350     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0181-5     Document Type: Article

References (23)

1. J Filicko HM Lazarus N Flomberg 2003 Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment Bone Marrow Transplant 31 1 10 10.1038/sj.bmt.1703776 (Pubitemid 36181815)
2. PF Coccia SE Strandjord PI Warkentin NK Cheung EM Gordon LJ Novak 1988 High-dose cytosine arabinoside and fractionated total-body irradiation: an improved preparative regimen for bone marrow transplantation of children with acute lymphoblastic leukemia in remission Blood 71 888 93 (Pubitemid 18111118)
3. S Riddell FR Appelbaum CD Buckner P Stewart R Clift J Sanders 1988 High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia J Clin Oncol 6 576 82 (Pubitemid 18106147)
4. N Kamani E Bayever CS August N Bunin JW Goldwein GJ D'Angio 1995 Fractionated toral-body irradiation preceding high-dose cytosine arabinoside as a preparative regimen for bone marrow transplantation in children with acute leukemia Med Pediatr Oncol 25 179 84 10.1002/mpo.2950250304
5. S Takahashi SI Okamoto N Shirafuji K Ikebuchi K Tani M Shimane 1994 Recombinant human glycosylated granulocyte colony-stimulating factor (rhG-CSF)-combined regimen for allogeneic bone marrow transplantation in refractory acute myeloid leukemia Bone Marrow Transplant 13 239 45 (Pubitemid 24065947)
6. S Okamoto S Takahashi M Wakui A Ishida R Tanosaki Y Ikeda 1999 Treatment of advanced myelodysplastic syndrome with a regimen including recombinant human granulocyte colony-stimulating factor preceding allogeneic bone marrow transplantation Br J Haematol 104 569 73 10.1046/j.1365-2141.1999.01205.x (Pubitemid 29119283)
7. T Mori R Yamazaki T Nakazato Y Aisa S Enoki M Arai 2006 Excretion of cytosine arabinoside in saliva after its administration at high doses Anticancer Drugs 17 597 8 10.1097/00001813-200606000-00015 (Pubitemid 44309977)
8. T Mori Y Aisa A Yokoyama T Nakazato R Yamazaki T Shimizu 2007 Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience Bone Marrow Transplant 39 217 21 10.1038/sj.bmt.1705578 (Pubitemid 46243264)
9. M Karthaus C Rosenthal A Ganse 1999 Prophylaxis and treatment of chemo- and radiotherapy-induced oral mucositis-are there new strategies? Bone Marrow Transplant 24 1095 108 10.1038/sj.bmt.1702024
10. DJ Mahood AM Dose CL Loprinzi MH Veeder LM Athmann TM Therneau 1991 Inhibition of fluorouracil-induced stomatitis by oral cryotherapy J Clin Oncol 9 449 52
11. LK Rocke CL Loprinzi JK Lee SJ Kunselman RK Iverson G Finck 1993 A randomized clinical trial of two different durations of oral cryotherapy for prevention of fluorouracil-related stomatitis Cancer 72 2234 8 doi:10.1002/1097-0142(19931001)72:7<2234::AID-CNCR2820720728>3.0.CO;2-N (Pubitemid 23280153)
12. G Meloni S Capria A Proia SM Trisolini F Mandelli 1996 Ice pops to prevent melphalan-induced stomatitis Lancet 347 1691 2 10.1016/S0140-6736(96) 91518-4
13. C Dumonet A Sonnet Y Bastion G Salles D Espinouse B Coiffier 1994 Prevention of high dose L-PAM-induced mucositis by cryotherapy Bone Marrow Transplant 3 492 4 (Pubitemid 24295255)
14. Y Aisa T Mori M Kudo T Yashima S Kondo A Yokoyama 2005 Oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients Support Care Cancer 13 266 9 10.1007/s00520-004-0726-y (Pubitemid 40576514)
15. T Mori R Yamazaki Y Aisa T Nakazato M Kudo T Yashima 2006 Brief oral cryotherapy for the prevention of high-dose melphalan-induced stomatitis in allogeneic hematopoietic stem cell transplant recipients Support Care Cancer 14 392 5 10.1007/s00520-005-0016-3
16. BN Stein NJ Petrelli HO Douglass DL Driscoll G Arcangeli NJ Meropol 1995 Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial Cancer 75 11 7 doi:10.1002/1097-0142(19950101)75: 1<11::AID-CNCR2820750104>3.0.CO;2-N
17. RA Popescu A Norman PJ Ross B Parikh D Cunningham 1999 Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older J Clin Oncol 17 2412 8 (Pubitemid 29368240)
18. D Crivellari M Bonetti M Castiglione-Gertsch RD Gelber CM Rudenstam B Thürlimann 2000 Burdens and benefits of adjuvant cyclophosphamide, methotrexate, and fluorouracil and tamoxifen for elderly patients with breast cancer: the international breast cancer study group trial VII J Clin Oncol 18 1412 22 (Pubitemid 30205386)
19. L Repetto 2003 Greater risks of chemotherapy toxicity in elderly patients with cancer J Support Oncol 1 Suppl 2 18 24
20. JD Hines MM Oken JJ Mazza AM Keller RR Streeter JH Glick 1984 High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia J Clin Oncol 2 545 9 (Pubitemid 14025605)
21. ER Grümayer W Schmidmeier S Panzer H Gadner 1986 Toxicity of sequential high-dose ARA-C asparaginase treatment in childhood poor risk leukemia Blut 53 309 14 10.1007/BF00320890 (Pubitemid 16031393)
22. WR Vogler HD Preisler EF Winton AJ Gottlieb J Goldberg J Brennan 1986 Randomized trial of high-dose cytarabine versus amsacrine in acute myelogenous leukemia in relapse: a leukemia intergroup study Cancer Treat Rep 70 455 9 (Pubitemid 16116446)
23. NJ Barrios CK Tebbi AI Freeman ML Brecher 1987 Toxicity of high dose Ara-C in children and adolescents Cancer 60 165 9 doi:10.1002/1097- 0142(19870715)60:2<165::AID-CNCR2820600207>3.0.CO;2-G (Pubitemid 17092250)